6 Apr 15

‘The introduction of this multinational, multicenter study shows DiObex ability. A major clinical program for the treatment of metabolic diseases, ‘CEO David Cory said. ‘With treatments for type 1 and type 2 diabetes mid-stage clinical trial and other data under evaluation for DIO-902 is DiObex well positioned to take a strong to move move in the later stages of development. ‘.

DiObex has two product candidates in Phase 2 clinical development. DIO-901 is in development as an extended release subcutaneous formulation for reducing or preventing insulin-induced hypoglycemia in type 1 diabetes mellitus. DIO-901 has received Fast Track status from the Food and Drug Administration. DIO-902 is a novel cortisol synthesis inhibitor in development for T2DM. Anomalies in cortisol activity may play an important role in the development of the metabolic syndrome, a constellation of conditions that place people at high risk for type 2 diabetes and cardiovascular disease. For more information, please visit.. About DiObexDiObex, San Francisco San Francisco founded to founded to develop novel products for the treatment of metabolic disorders.These forward-looking statements speak only as of the date hereof. Genomic Health undertakes no obligation to update any forward-looking statements.. This news release contains forward looking statements as Private Securities Litigation Reform Act of 1995, including the statements related to the application of clinical study results to actual results and the Company’s intentions, the the Oncotype DX colon cancer Recurrence Score do available doctor and patients in early 2010. Forward-looking statements are subject to risks and uncertainties cause actual results to vary materially, and reported results should be do not will be previewed an indicator of of future performance.

Cautionary Statement Regarding Forward – Looking StatementsThis release contains forward-looking statements within the meaning of Section 21E of of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words such as anticipate , expect , can be identified, project , believe , plan , estimate , intend and similar lyrics. Forward-looking statements based on our beliefs, assumptions estimates and using information that enables us about the date, and are not intended as guarantees of future events or performance.